High expression of GTSE1 is consistently linked to poor overall survival in 11 types of tumors, including ACC, indicating it as a risk factor (HR > 1, p < 0.05; Figure 3A) associated with shorter survival time for patients (p < 0.05; Figure 3B). This evidence concerns the gene GTSE1 and adrenal cortex carcinoma.